AVR Anteris Technologies Global Corp.
Healthcare$9.08-5.61%ClosedMarket Cap: $334.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.81
P/S
191.20
EV/EBITDA
-0.79
DCF Value
$-1.07
FCF Yield
-24.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
28.3%
Operating Margin
-5192.9%
Net Margin
-5148.8%
ROE
-124.4%
ROA
-32.3%
ROIC
-34.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $494.0K | -9.9% | $-24.0M | $-23.0M | $— | — |
| Q4 null | $310.0K | -65.8% | $-29.0M | $-29.2M | $— | — |
| FY null | $1.9M | -16.6% | $-93.9M | $-94.1M | $— | — |
| Q3 null | $429.0K | 71.3% | $-22.3M | $-22.2M | $— | — |
| Q2 null | $618.0K | 76.1% | $-20.9M | $-20.8M | $— | — |
| Q1 null | $556.0K | 62.8% | $-21.8M | $-21.9M | $— | — |
| Q4 null | $536.1K | 61.2% | $-21.1M | $-19.4M | $— | — |
| FY null | $2.7M | 46.8% | $-78.4M | $-76.3M | $— | — |
| Q3 null | $769.0K | 42.3% | $-21.9M | $-21.9M | $— | — |
| Q2 null | $631.5K | 50.6% | $-18.9M | $-18.7M | $— | — |
| Q1 null | $766.0K | 38.3% | $-17.8M | $-16.4M | $— | — |
| Q4 2023 | $544.2K | 34.3% | $-15.9M | $-14.2M | $-0.39 | — |